AMED News Alert Amedisys Inc (AMED) 28.97 12/25/2014 09:15:1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amedisys Inc (AMED) 28.97 $AMED

Top 3 Industries Ready to Take Off in 2015 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 1:34PM CST
The best way to narrow down your search for "big game" stocks in a volatile market is to resort to some expert advice like the Zacks Industry Rank.
TQNT: 27.72 (+0.50), CTP: 14.57 (-0.18), AMED: 28.97 (-0.08)

How to Invest Money: This Secret Could Save You Thousands
Brian Stoffel, The Motley Fool - Motley Fool - Mon Dec 22, 8:00AM CST
The secret of how to invest money is so simple these kids could get it right. Photo: Flickr user Mike King. Here at The Motley Fool, we try to avoid giving blanket advice on investing, because there are as many paths to financial independence as...
BEBE: 2.48 (-0.15), BIIB: 340.89 (+5.13), PSUN: 2.07 (+0.05), RECN: 16.41 (+0.22), VALU: 16.26 (+0.68), GRMN: 53.86 (+0.50), QSII: 15.73 (+0.23), AMED: 28.97 (-0.08), UMPQ: 17.28 (+0.06), YHOO: 50.65 (+0.63), RCL: 82.36 (+0.16), IART: 53.68 (+0.32), ATLC: 2.50 (+0.01), AEO: 13.53 (+0.02), ARMH: 46.80 (+0.46), CEB: 73.03 (+0.23), GPS: 41.46 (+0.09)

Uptrend Call Working As Amedisys Stock Rises 72.9% (AMED)
Comtex SmarTrend(R) - Wed Dec 17, 4:44PM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 6 months, Amedisys has returned 72.95% as of today's recent price of $27.68.
AMED: 28.97 (-0.08)

DaVita to Merge Business Units, Advance Clinical Research - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 12:40PM CST
DaVita HealthCare Partners Inc.'s (DVA) business units ??? DaVita Clinical Research (DCR) and HealthCare Partners Clinical Research ??? are set to merge.
AFAM: 29.53 (-0.06), DVA: 76.06 (+0.07), AMED: 28.97 (-0.08), GTIV: 19.07 (unch)

New chief at Amedisys
Seeking Alpha - at Seeking Alpha - Tue Dec 16, 8:39AM CST

AMED: 28.97 (-0.08)

Amedisys Board Names Paul B. Kusserow as New CEO
GlobeNewswire - Tue Dec 16, 7:37AM CST
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today announced that its Board of Directors has named Paul B. Kusserow as President and Chief Executive Officer and member of the Board of Directors. Kusserow will assume the role on December 16, 2014 from President and Interim CEO, Ronald LaBorde, who will remain a member of the senior management team in the role of Vice Chairman reporting directly to the CEO. LaBorde will also continue to serve as a member of the Board of Directors.
CNXR: 8.90 (+0.15), AMED: 28.97 (-0.08)

United States Home Health and Hospice Care Industry Analytics 2014-2021 - Market to reach $141 Billion by 2021
M2 - Mon Dec 15, 8:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/8wh7p6/home_health_and) has announced the addition of Plunkett Research Ltd's new report "Home Health and Hospice Care Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 621600" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Home Health and Hospice Care Industry (U.S.) to reach $131.3 billion by 2021. - Home Health and Hospice Care Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Addus Homecare Corp - Almost Family Inc - Amedisys Inc - American HomePatient Inc - Apria Healthcare Group Inc - BioScrip Inc - Chemed Corporation - Gentiva Health Services Inc - LHC Group Inc - Lincare Holdings Inc For more information visit http://www.researchandmarkets.com/research/8w...health_and Source: Plunkett Research Ltd
CHE: 106.16 (+0.13), AFAM: 29.53 (-0.06), LHCG: 30.33 (-0.21), BIOS: 6.37 (unch), AMED: 28.97 (-0.08), GTIV: 19.07 (unch)

Quest Diagnostics' Virus Test Kit Wins FDA Clearance Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 2:40PM CST
Studies conducted by Quest Diagnostics (DGX) over time have shown that the Simplexa test kit can offer fast, reliable results within an hour.
CHE: 106.16 (+0.13), AFAM: 29.53 (-0.06), DGX: 67.94 (-0.16), AMED: 28.97 (-0.08)

Amedisys Has Returned 67.9% Since SmarTrend Recommendation (AMED)
Comtex SmarTrend(R) - Wed Dec 10, 10:58AM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 6 months, Amedisys has returned 67.89% as of today's recent price of $26.87.
AMED: 28.97 (-0.08)

Amedisys to Present at the 25th Annual Oppenheimer Healthcare Conference
GlobeNewswire - Wed Dec 10, 10:00AM CST
Amedisys, Inc. (Nasdaq:AMED), one of America's leading healthcare at home companies, today announced that Dale E. Redman, Interim Chief Financial Officer, will present at the 25 Annual Oppenheimer Healthcare Conference in New York, NY on Thursday, December 11, 2014.
AMED: 28.97 (-0.08)

The Right Time to Invest in Amedisys (AMED)? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 4:15PM CST
On Dec 8, 2014, we issued an updated research report on Amedisys Inc. (AMED).
CHE: 106.16 (+0.13), AFAM: 29.53 (-0.06), AMED: 28.97 (-0.08), GTIV: 19.07 (unch)

Why the P/S Ratio is My Favorite Valuation Metric - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Dec 09, 12:00AM CST
Why the P/S Ratio is My Favorite Valuation Metric - Screen of the Week
SYKE: 23.48 (-0.13), KR: 64.05 (-0.23), HA: 24.44 (+0.51), AMED: 28.97 (-0.08), CDW: 35.75 (+0.14)

Is Merge Healthcare (MRGE) a Buy after Strong Q3 Results? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 1:40PM CST
On Dec 5, 2014, we issued an updated research report on Merge Healthcare Incorporated (MRGE).
ICUI: 83.38 (+1.63), AMED: 28.97 (-0.08), MRGE: 3.59 (+0.05), OSUR: 10.26 (+0.25)

Shares of AMED Up 63.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Dec 03, 9:36AM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 5 months, Amedisys has returned 63.01% as of today's recent price of $26.09.
AMED: 28.97 (-0.08)

Market Has Not Yet Noticed Potential in Amedisys (AMED); Have You? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 28, 7:32AM CST
One company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Amedisys Inc. (AMED).
AMED: 28.97 (-0.08)

Amedisys Up 62.6% Since SmarTrend Uptrend Call (AMED)
Comtex SmarTrend(R) - Wed Nov 26, 9:09AM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 5 months, Amedisys has returned 62.57% as of today's recent price of $26.02.
AMED: 28.97 (-0.08)

Amedisys Inc. (AMED): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 7:32AM CST
This is because Amedisys Inc. (AMED) in the Medical-Outpatient space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
AMED: 28.97 (-0.08)

Comparing America's 3 Largest Home Health Care Companies
Joseph Cafariello - at Seeking Alpha - Fri Nov 21, 6:50AM CST

CHE: 106.16 (+0.13), AMED: 28.97 (-0.08), GTIV: 19.07 (unch)

Shares of AMED Up 56.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Nov 18, 4:47PM CST
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 5 months, Amedisys has returned 56.58% as of today's recent price of $25.06.
AMED: 28.97 (-0.08)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 108

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
Lennar's 6.73% Slide Puts Disclosure Claims in Focus

Updated Category News Views 12

A homebuilder can survive ugly margins; murky demand signals are another beast entirely. Lennar is staring at a securities class action after a bruising run of disclosures and market reactions, and the central issue is not whether housing got tougher. Everybody with a pulse knew rates were squeezing buyers. The issue is whether NYSE:LEN gave investors a sufficiently clear...

Continue Reading
AlphaPoint's Approval Device Targets AI Attack Risk

Updated Category News Views 45

A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...

Continue Reading
Industrial Air Compressors: Fix, Rebuild, or Replace

Updated Category News Views 90

A compressor’s ugliest invoice is rarely the one from the service technician. It is the one nobody sees at first: a stalled production line, missed output, overtime, wasted electricity, and a maintenance crew chasing the same machine again next month. Pam Mahood of Waterloo, Iowa-based Compressed Air & Equipment Co. puts the decision where it belongs—not on the price...

Continue Reading
Hoymiles Brings Plug-In Solar Flexibility to RE+ 2026

Updated Category News Views 105

A 1.8-kilogram box may not sound like much, but it captures where household solar is trying to go: smaller, less intimidating, and far easier to put to work. At RE+ 2026 in Las Vegas, Hoymiles laid out a residential lineup spanning plug-in solar, battery storage and conventional rooftop microinverters. This was not one flashy gadget looking for applause. It was a fairly...

Continue Reading
Triller Lawsuit Puts Merger Disclosures Under a Harsh Light

Updated Category News Views 90

A $0.32 closing price has a way of stripping the paint off a corporate story. The proposed securities class action involving Triller Group, Inc. puts a hard spotlight on a familiar, ugly market sequence: a splashy merger, glowing talk around acquired assets, delayed financial filings, Nasdaq trouble, and then a collapse severe enough to leave shareholders wondering what...

Continue Reading
Sports Leagues Confront Youth Gambling's Hard Truth

Updated Category News Views 70

A stadium-sized advertising machine cannot pretend kids are not watching. That is the uncomfortable backdrop to the National Council on Problem Gambling's November 10 youth gambling prevention summit, where representatives from the NFL, MLB, NBA and PGA Tour met at the NFL's New York offices. Good that they showed up. Frankly, with gambling stitched into so much sports...

Continue Reading
Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 149

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Sustainability LIVE: The Middle East Summit 2026 Insights

Updated Category News Views 218

BizClik Announces Sustainability LIVE: The Middle East Summit BizClik, the renowned global B2B media company behind the well-known Sustainability Magazine, is setting the stage for an ambitious event called Sustainability LIVE: The Middle East Summit. This summit is scheduled to take place virtually from 3-4 February 2026, providing a unique opportunity for leaders in...

Continue Reading
Bureau Veritas Ceases Discussions on Business Merger Plans

Updated Category News Views 137

Bureau Veritas Concludes Discussions on Future Collaboration In a recent declaration, Bureau Veritas disclosed that discussions surrounding a potential merger with SGS have ceased. The talks, which commenced with optimism about the potential synergies between the two leading firms in the Testing, Inspection, and Certification (TIC) industry, did not reach a conclusive...

Continue Reading
Bernstein's Insights: Why Royal Caribbean Outshines Carnival

Updated Category News Views 295

Bernstein Analyzes the Cruise Industry Landscape Recently, Bernstein analysts took a deep dive into the cruise industry, comparing two major players: Royal Caribbean (NYSE: RCL) and Carnival (NYSE: CCL). The analysts have awarded an Outperform rating to Royal Caribbean while assigning a Market-Perform rating to Carnival, based on recent assessments of the sector....

Continue Reading
NRG Energy's Impressive Q4 Performance and Exciting Future Plans

Updated Category News Views 498

NRG Energy Reports Strong Fourth Quarter Performance NRG Energy, Inc. (NYSE: NRG) has witnessed an uptick in its stock price following the announcement of its fourth-quarter results for 2024. Despite missing revenue expectations, the company demonstrated remarkable profitability. Revenue and Earnings Overview During the fourth quarter, NRG Energy reported revenues of...

Continue Reading
OpenText Introduces Cutting-Edge AI Platform for Enterprises

Updated Category News Views 317

Transforming Data Management with AI Technology OpenText has unveiled an exciting new platform that revolutionizes how enterprises manage their data. This next-generation AI Data Platform streamlines data management while incorporating innovative AI capabilities that empower organizations to activate their information securely. As the digital landscape continues to...

Continue Reading